Biotech news
Americas
The Massachusetts Institute of Technology has succeeded in a patent infringement case against Shire Pharmaceuticals. 14 October 2016
Africa
‘Technological intelligence’ is very important for extracting maximum value from technology transfer deals, and life sciences companies should use it to their advantage, says Montserrat González-Álvarez of Leyva, Montenegro, Trigueros Abogados. 14 October 2016
Biotech
New legislation in Brazil aims to create a balance between using genetic resources for scientific advancement and spreading the benefits among local communities fairly, as Gabriel Di Blasi of Di Blasi, Parente & Associados and Eduardo Emrich of Biominas Brasil explain. 13 October 2016
Africa
In a world where research projects are increasingly carried out by several parties in different countries, companies should consider a number of IP-related issues before embarking on multiterritorial collaborations, say Oliver Laing and Tony Proctor of Potter Clarkson. 12 October 2016
Asia
Over the past few years China’s life sciences sector has become a hive of activity as specialist IP courts have been implemented and M&A activity has ramped up. LSIPR assesses some of these developments. 11 October 2016
Pharma
In September 2016, the Francis Crick Institute opened the doors to its multimillion-pound new home in London. With a wide range of research being undertaken, LSIPR examines the role of IP and the associated challenges for the organisation. 11 October 2016
Biotech
Dolly the Sheep, which would have been 20 this year, raised the possibility of cloning and forced politicians and IP practitioners to address the ethics of the process, with differing results in the US and the UK, as LSIPR reports. 10 October 2016
Americas
Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada. 7 October 2016
Pharma
On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points. 7 October 2016
Americas
Robert Nelsen and Bryan Roberts were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Nelsen and Roberts were featured in the investment section, as LSIPR reports. 5 October 2016